Abstract
This article presents an Executive Summary of the conclusions and recommendations of the 10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July 2017 issue of The Ocular Surface. A downloadable version of the document and additional material, including videos of diagnostic and management techniques, are available on the TFOS website: www.TearFilm.org.
| Original language | English |
|---|---|
| Pages (from-to) | 802-812 |
| Journal | Ocular Surface |
| Volume | 15 |
| Issue number | 4 |
| Early online date | 8 Aug 2017 |
| DOIs | |
| Publication status | Published - 1 Oct 2017 |
Bibliographical note
© 2017, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/. This is a 'Free' Special Article.
Funding: TFOS DEWS II was supported by unrestricted donations from Alcon, Novartis, Shire, Allergan, Bausch + Lomb, Akorn, CooperVision, Dompé, Horus Pharma, Lμbris Biopharma, Oculeve, TearLab, Laboratoires Théa, SIFI, Sun Pharma, Johnson & Johnson VisionCare, Carl Zeiss Meditec, Quint Health, Scope Ophthalmics and Senju.
Fingerprint
Dive into the research topics of 'TFOS DEWS II Report Executive Summary'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver